← FDA Drug Approvals (Drugs@FDA)

COUMADIN

NDA · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 1954-06-08

Drug application

FDA Application #

NDA009218

Application type

New Drug Application

Brand name

COUMADIN

Generic name

Warfarin Sodium

Active ingredients

WARFARIN SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

BRISTOL MYERS SQUIBB

First approval

1954-06-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown